Global Mono Hepatitis A Vaccine Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.
LPI (LP Information)' newest research report, the “Mono Hepatitis A Vaccine Industry Forecast” looks at past sales and reviews total world Mono Hepatitis A Vaccine sales in 2022, providing a comprehensive analysis by region and market sector of projected Mono Hepatitis A Vaccine sales for 2023 through 2029. With Mono Hepatitis A Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Mono Hepatitis A Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Mono Hepatitis A Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Mono Hepatitis A Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Mono Hepatitis A Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Mono Hepatitis A Vaccine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Mono Hepatitis A Vaccine.
The global Mono Hepatitis A Vaccine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Mono Hepatitis A Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Mono Hepatitis A Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Mono Hepatitis A Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Mono Hepatitis A Vaccine players cover GSK, Merck, Sanofi, Sinovac, Zhejiang Pukang, Changchun Institute of Biological, Kaketsuken, IMBCA and ChangSheng, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Mono Hepatitis A Vaccine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Mono Hepatitis A Vaccine market?
What factors are driving Mono Hepatitis A Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Mono Hepatitis A Vaccine market opportunities vary by end market size?
How does Mono Hepatitis A Vaccine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.
LPI (LP Information)' newest research report, the “Mono Hepatitis A Vaccine Industry Forecast” looks at past sales and reviews total world Mono Hepatitis A Vaccine sales in 2022, providing a comprehensive analysis by region and market sector of projected Mono Hepatitis A Vaccine sales for 2023 through 2029. With Mono Hepatitis A Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Mono Hepatitis A Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Mono Hepatitis A Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Mono Hepatitis A Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Mono Hepatitis A Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Mono Hepatitis A Vaccine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Mono Hepatitis A Vaccine.
The global Mono Hepatitis A Vaccine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Mono Hepatitis A Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Mono Hepatitis A Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Mono Hepatitis A Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Mono Hepatitis A Vaccine players cover GSK, Merck, Sanofi, Sinovac, Zhejiang Pukang, Changchun Institute of Biological, Kaketsuken, IMBCA and ChangSheng, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Mono Hepatitis A Vaccine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Inactivated Vaccine
- Live Attenuated Vaccine
- Government Institution
- Private Sector
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- GSK
- Merck
- Sanofi
- Sinovac
- Zhejiang Pukang
- Changchun Institute of Biological
- Kaketsuken
- IMBCA
- ChangSheng
- Convac
What is the 10-year outlook for the global Mono Hepatitis A Vaccine market?
What factors are driving Mono Hepatitis A Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Mono Hepatitis A Vaccine market opportunities vary by end market size?
How does Mono Hepatitis A Vaccine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Mono Hepatitis A Vaccine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Mono Hepatitis A Vaccine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Mono Hepatitis A Vaccine by Country/Region, 2018, 2022 & 2029
2.2 Mono Hepatitis A Vaccine Segment by Type
2.2.1 Inactivated Vaccine
2.2.2 Live Attenuated Vaccine
2.3 Mono Hepatitis A Vaccine Sales by Type
2.3.1 Global Mono Hepatitis A Vaccine Sales Market Share by Type (2018-2023)
2.3.2 Global Mono Hepatitis A Vaccine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Mono Hepatitis A Vaccine Sale Price by Type (2018-2023)
2.4 Mono Hepatitis A Vaccine Segment by Application
2.4.1 Government Institution
2.4.2 Private Sector
2.4.3 Other
2.5 Mono Hepatitis A Vaccine Sales by Application
2.5.1 Global Mono Hepatitis A Vaccine Sale Market Share by Application (2018-2023)
2.5.2 Global Mono Hepatitis A Vaccine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Mono Hepatitis A Vaccine Sale Price by Application (2018-2023)
3 GLOBAL MONO HEPATITIS A VACCINE BY COMPANY
3.1 Global Mono Hepatitis A Vaccine Breakdown Data by Company
3.1.1 Global Mono Hepatitis A Vaccine Annual Sales by Company (2018-2023)
3.1.2 Global Mono Hepatitis A Vaccine Sales Market Share by Company (2018-2023)
3.2 Global Mono Hepatitis A Vaccine Annual Revenue by Company (2018-2023)
3.2.1 Global Mono Hepatitis A Vaccine Revenue by Company (2018-2023)
3.2.2 Global Mono Hepatitis A Vaccine Revenue Market Share by Company (2018-2023)
3.3 Global Mono Hepatitis A Vaccine Sale Price by Company
3.4 Key Manufacturers Mono Hepatitis A Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Mono Hepatitis A Vaccine Product Location Distribution
3.4.2 Players Mono Hepatitis A Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR MONO HEPATITIS A VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Mono Hepatitis A Vaccine Market Size by Geographic Region (2018-2023)
4.1.1 Global Mono Hepatitis A Vaccine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Mono Hepatitis A Vaccine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Mono Hepatitis A Vaccine Market Size by Country/Region (2018-2023)
4.2.1 Global Mono Hepatitis A Vaccine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Mono Hepatitis A Vaccine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Mono Hepatitis A Vaccine Sales Growth
4.4 APAC Mono Hepatitis A Vaccine Sales Growth
4.5 Europe Mono Hepatitis A Vaccine Sales Growth
4.6 Middle East & Africa Mono Hepatitis A Vaccine Sales Growth
5 AMERICAS
5.1 Americas Mono Hepatitis A Vaccine Sales by Country
5.1.1 Americas Mono Hepatitis A Vaccine Sales by Country (2018-2023)
5.1.2 Americas Mono Hepatitis A Vaccine Revenue by Country (2018-2023)
5.2 Americas Mono Hepatitis A Vaccine Sales by Type
5.3 Americas Mono Hepatitis A Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Mono Hepatitis A Vaccine Sales by Region
6.1.1 APAC Mono Hepatitis A Vaccine Sales by Region (2018-2023)
6.1.2 APAC Mono Hepatitis A Vaccine Revenue by Region (2018-2023)
6.2 APAC Mono Hepatitis A Vaccine Sales by Type
6.3 APAC Mono Hepatitis A Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Mono Hepatitis A Vaccine by Country
7.1.1 Europe Mono Hepatitis A Vaccine Sales by Country (2018-2023)
7.1.2 Europe Mono Hepatitis A Vaccine Revenue by Country (2018-2023)
7.2 Europe Mono Hepatitis A Vaccine Sales by Type
7.3 Europe Mono Hepatitis A Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Mono Hepatitis A Vaccine by Country
8.1.1 Middle East & Africa Mono Hepatitis A Vaccine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Mono Hepatitis A Vaccine Revenue by Country (2018-2023)
8.2 Middle East & Africa Mono Hepatitis A Vaccine Sales by Type
8.3 Middle East & Africa Mono Hepatitis A Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Mono Hepatitis A Vaccine
10.3 Manufacturing Process Analysis of Mono Hepatitis A Vaccine
10.4 Industry Chain Structure of Mono Hepatitis A Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Mono Hepatitis A Vaccine Distributors
11.3 Mono Hepatitis A Vaccine Customer
12 WORLD FORECAST REVIEW FOR MONO HEPATITIS A VACCINE BY GEOGRAPHIC REGION
12.1 Global Mono Hepatitis A Vaccine Market Size Forecast by Region
12.1.1 Global Mono Hepatitis A Vaccine Forecast by Region (2024-2029)
12.1.2 Global Mono Hepatitis A Vaccine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Mono Hepatitis A Vaccine Forecast by Type
12.7 Global Mono Hepatitis A Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 GSK
13.1.1 GSK Company Information
13.1.2 GSK Mono Hepatitis A Vaccine Product Portfolios and Specifications
13.1.3 GSK Mono Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 GSK Main Business Overview
13.1.5 GSK Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Mono Hepatitis A Vaccine Product Portfolios and Specifications
13.2.3 Merck Mono Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi Mono Hepatitis A Vaccine Product Portfolios and Specifications
13.3.3 Sanofi Mono Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 Sinovac
13.4.1 Sinovac Company Information
13.4.2 Sinovac Mono Hepatitis A Vaccine Product Portfolios and Specifications
13.4.3 Sinovac Mono Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Sinovac Main Business Overview
13.4.5 Sinovac Latest Developments
13.5 Zhejiang Pukang
13.5.1 Zhejiang Pukang Company Information
13.5.2 Zhejiang Pukang Mono Hepatitis A Vaccine Product Portfolios and Specifications
13.5.3 Zhejiang Pukang Mono Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Zhejiang Pukang Main Business Overview
13.5.5 Zhejiang Pukang Latest Developments
13.6 Changchun Institute of Biological
13.6.1 Changchun Institute of Biological Company Information
13.6.2 Changchun Institute of Biological Mono Hepatitis A Vaccine Product Portfolios and Specifications
13.6.3 Changchun Institute of Biological Mono Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Changchun Institute of Biological Main Business Overview
13.6.5 Changchun Institute of Biological Latest Developments
13.7 Kaketsuken
13.7.1 Kaketsuken Company Information
13.7.2 Kaketsuken Mono Hepatitis A Vaccine Product Portfolios and Specifications
13.7.3 Kaketsuken Mono Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Kaketsuken Main Business Overview
13.7.5 Kaketsuken Latest Developments
13.8 IMBCA
13.8.1 IMBCA Company Information
13.8.2 IMBCA Mono Hepatitis A Vaccine Product Portfolios and Specifications
13.8.3 IMBCA Mono Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 IMBCA Main Business Overview
13.8.5 IMBCA Latest Developments
13.9 ChangSheng
13.9.1 ChangSheng Company Information
13.9.2 ChangSheng Mono Hepatitis A Vaccine Product Portfolios and Specifications
13.9.3 ChangSheng Mono Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 ChangSheng Main Business Overview
13.9.5 ChangSheng Latest Developments
13.10 Convac
13.10.1 Convac Company Information
13.10.2 Convac Mono Hepatitis A Vaccine Product Portfolios and Specifications
13.10.3 Convac Mono Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Convac Main Business Overview
13.10.5 Convac Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Mono Hepatitis A Vaccine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Mono Hepatitis A Vaccine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Mono Hepatitis A Vaccine by Country/Region, 2018, 2022 & 2029
2.2 Mono Hepatitis A Vaccine Segment by Type
2.2.1 Inactivated Vaccine
2.2.2 Live Attenuated Vaccine
2.3 Mono Hepatitis A Vaccine Sales by Type
2.3.1 Global Mono Hepatitis A Vaccine Sales Market Share by Type (2018-2023)
2.3.2 Global Mono Hepatitis A Vaccine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Mono Hepatitis A Vaccine Sale Price by Type (2018-2023)
2.4 Mono Hepatitis A Vaccine Segment by Application
2.4.1 Government Institution
2.4.2 Private Sector
2.4.3 Other
2.5 Mono Hepatitis A Vaccine Sales by Application
2.5.1 Global Mono Hepatitis A Vaccine Sale Market Share by Application (2018-2023)
2.5.2 Global Mono Hepatitis A Vaccine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Mono Hepatitis A Vaccine Sale Price by Application (2018-2023)
3 GLOBAL MONO HEPATITIS A VACCINE BY COMPANY
3.1 Global Mono Hepatitis A Vaccine Breakdown Data by Company
3.1.1 Global Mono Hepatitis A Vaccine Annual Sales by Company (2018-2023)
3.1.2 Global Mono Hepatitis A Vaccine Sales Market Share by Company (2018-2023)
3.2 Global Mono Hepatitis A Vaccine Annual Revenue by Company (2018-2023)
3.2.1 Global Mono Hepatitis A Vaccine Revenue by Company (2018-2023)
3.2.2 Global Mono Hepatitis A Vaccine Revenue Market Share by Company (2018-2023)
3.3 Global Mono Hepatitis A Vaccine Sale Price by Company
3.4 Key Manufacturers Mono Hepatitis A Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Mono Hepatitis A Vaccine Product Location Distribution
3.4.2 Players Mono Hepatitis A Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR MONO HEPATITIS A VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Mono Hepatitis A Vaccine Market Size by Geographic Region (2018-2023)
4.1.1 Global Mono Hepatitis A Vaccine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Mono Hepatitis A Vaccine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Mono Hepatitis A Vaccine Market Size by Country/Region (2018-2023)
4.2.1 Global Mono Hepatitis A Vaccine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Mono Hepatitis A Vaccine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Mono Hepatitis A Vaccine Sales Growth
4.4 APAC Mono Hepatitis A Vaccine Sales Growth
4.5 Europe Mono Hepatitis A Vaccine Sales Growth
4.6 Middle East & Africa Mono Hepatitis A Vaccine Sales Growth
5 AMERICAS
5.1 Americas Mono Hepatitis A Vaccine Sales by Country
5.1.1 Americas Mono Hepatitis A Vaccine Sales by Country (2018-2023)
5.1.2 Americas Mono Hepatitis A Vaccine Revenue by Country (2018-2023)
5.2 Americas Mono Hepatitis A Vaccine Sales by Type
5.3 Americas Mono Hepatitis A Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Mono Hepatitis A Vaccine Sales by Region
6.1.1 APAC Mono Hepatitis A Vaccine Sales by Region (2018-2023)
6.1.2 APAC Mono Hepatitis A Vaccine Revenue by Region (2018-2023)
6.2 APAC Mono Hepatitis A Vaccine Sales by Type
6.3 APAC Mono Hepatitis A Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Mono Hepatitis A Vaccine by Country
7.1.1 Europe Mono Hepatitis A Vaccine Sales by Country (2018-2023)
7.1.2 Europe Mono Hepatitis A Vaccine Revenue by Country (2018-2023)
7.2 Europe Mono Hepatitis A Vaccine Sales by Type
7.3 Europe Mono Hepatitis A Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Mono Hepatitis A Vaccine by Country
8.1.1 Middle East & Africa Mono Hepatitis A Vaccine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Mono Hepatitis A Vaccine Revenue by Country (2018-2023)
8.2 Middle East & Africa Mono Hepatitis A Vaccine Sales by Type
8.3 Middle East & Africa Mono Hepatitis A Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Mono Hepatitis A Vaccine
10.3 Manufacturing Process Analysis of Mono Hepatitis A Vaccine
10.4 Industry Chain Structure of Mono Hepatitis A Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Mono Hepatitis A Vaccine Distributors
11.3 Mono Hepatitis A Vaccine Customer
12 WORLD FORECAST REVIEW FOR MONO HEPATITIS A VACCINE BY GEOGRAPHIC REGION
12.1 Global Mono Hepatitis A Vaccine Market Size Forecast by Region
12.1.1 Global Mono Hepatitis A Vaccine Forecast by Region (2024-2029)
12.1.2 Global Mono Hepatitis A Vaccine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Mono Hepatitis A Vaccine Forecast by Type
12.7 Global Mono Hepatitis A Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 GSK
13.1.1 GSK Company Information
13.1.2 GSK Mono Hepatitis A Vaccine Product Portfolios and Specifications
13.1.3 GSK Mono Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 GSK Main Business Overview
13.1.5 GSK Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Mono Hepatitis A Vaccine Product Portfolios and Specifications
13.2.3 Merck Mono Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi Mono Hepatitis A Vaccine Product Portfolios and Specifications
13.3.3 Sanofi Mono Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 Sinovac
13.4.1 Sinovac Company Information
13.4.2 Sinovac Mono Hepatitis A Vaccine Product Portfolios and Specifications
13.4.3 Sinovac Mono Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Sinovac Main Business Overview
13.4.5 Sinovac Latest Developments
13.5 Zhejiang Pukang
13.5.1 Zhejiang Pukang Company Information
13.5.2 Zhejiang Pukang Mono Hepatitis A Vaccine Product Portfolios and Specifications
13.5.3 Zhejiang Pukang Mono Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Zhejiang Pukang Main Business Overview
13.5.5 Zhejiang Pukang Latest Developments
13.6 Changchun Institute of Biological
13.6.1 Changchun Institute of Biological Company Information
13.6.2 Changchun Institute of Biological Mono Hepatitis A Vaccine Product Portfolios and Specifications
13.6.3 Changchun Institute of Biological Mono Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Changchun Institute of Biological Main Business Overview
13.6.5 Changchun Institute of Biological Latest Developments
13.7 Kaketsuken
13.7.1 Kaketsuken Company Information
13.7.2 Kaketsuken Mono Hepatitis A Vaccine Product Portfolios and Specifications
13.7.3 Kaketsuken Mono Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Kaketsuken Main Business Overview
13.7.5 Kaketsuken Latest Developments
13.8 IMBCA
13.8.1 IMBCA Company Information
13.8.2 IMBCA Mono Hepatitis A Vaccine Product Portfolios and Specifications
13.8.3 IMBCA Mono Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 IMBCA Main Business Overview
13.8.5 IMBCA Latest Developments
13.9 ChangSheng
13.9.1 ChangSheng Company Information
13.9.2 ChangSheng Mono Hepatitis A Vaccine Product Portfolios and Specifications
13.9.3 ChangSheng Mono Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 ChangSheng Main Business Overview
13.9.5 ChangSheng Latest Developments
13.10 Convac
13.10.1 Convac Company Information
13.10.2 Convac Mono Hepatitis A Vaccine Product Portfolios and Specifications
13.10.3 Convac Mono Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Convac Main Business Overview
13.10.5 Convac Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Mono Hepatitis A Vaccine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Mono Hepatitis A Vaccine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Inactivated Vaccine
Table 4. Major Players of Live Attenuated Vaccine
Table 5. Global Mono Hepatitis A Vaccine Sales by Type (2018-2023) & (K Units)
Table 6. Global Mono Hepatitis A Vaccine Sales Market Share by Type (2018-2023)
Table 7. Global Mono Hepatitis A Vaccine Revenue by Type (2018-2023) & ($ million)
Table 8. Global Mono Hepatitis A Vaccine Revenue Market Share by Type (2018-2023)
Table 9. Global Mono Hepatitis A Vaccine Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Mono Hepatitis A Vaccine Sales by Application (2018-2023) & (K Units)
Table 11. Global Mono Hepatitis A Vaccine Sales Market Share by Application (2018-2023)
Table 12. Global Mono Hepatitis A Vaccine Revenue by Application (2018-2023)
Table 13. Global Mono Hepatitis A Vaccine Revenue Market Share by Application (2018-2023)
Table 14. Global Mono Hepatitis A Vaccine Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Mono Hepatitis A Vaccine Sales by Company (2018-2023) & (K Units)
Table 16. Global Mono Hepatitis A Vaccine Sales Market Share by Company (2018-2023)
Table 17. Global Mono Hepatitis A Vaccine Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Mono Hepatitis A Vaccine Revenue Market Share by Company (2018-2023)
Table 19. Global Mono Hepatitis A Vaccine Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Mono Hepatitis A Vaccine Producing Area Distribution and Sales Area
Table 21. Players Mono Hepatitis A Vaccine Products Offered
Table 22. Mono Hepatitis A Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Mono Hepatitis A Vaccine Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Mono Hepatitis A Vaccine Sales Market Share Geographic Region (2018-2023)
Table 27. Global Mono Hepatitis A Vaccine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Mono Hepatitis A Vaccine Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Mono Hepatitis A Vaccine Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Mono Hepatitis A Vaccine Sales Market Share by Country/Region (2018-2023)
Table 31. Global Mono Hepatitis A Vaccine Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Mono Hepatitis A Vaccine Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Mono Hepatitis A Vaccine Sales by Country (2018-2023) & (K Units)
Table 34. Americas Mono Hepatitis A Vaccine Sales Market Share by Country (2018-2023)
Table 35. Americas Mono Hepatitis A Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Mono Hepatitis A Vaccine Revenue Market Share by Country (2018-2023)
Table 37. Americas Mono Hepatitis A Vaccine Sales by Type (2018-2023) & (K Units)
Table 38. Americas Mono Hepatitis A Vaccine Sales by Application (2018-2023) & (K Units)
Table 39. APAC Mono Hepatitis A Vaccine Sales by Region (2018-2023) & (K Units)
Table 40. APAC Mono Hepatitis A Vaccine Sales Market Share by Region (2018-2023)
Table 41. APAC Mono Hepatitis A Vaccine Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Mono Hepatitis A Vaccine Revenue Market Share by Region (2018-2023)
Table 43. APAC Mono Hepatitis A Vaccine Sales by Type (2018-2023) & (K Units)
Table 44. APAC Mono Hepatitis A Vaccine Sales by Application (2018-2023) & (K Units)
Table 45. Europe Mono Hepatitis A Vaccine Sales by Country (2018-2023) & (K Units)
Table 46. Europe Mono Hepatitis A Vaccine Sales Market Share by Country (2018-2023)
Table 47. Europe Mono Hepatitis A Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Mono Hepatitis A Vaccine Revenue Market Share by Country (2018-2023)
Table 49. Europe Mono Hepatitis A Vaccine Sales by Type (2018-2023) & (K Units)
Table 50. Europe Mono Hepatitis A Vaccine Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Mono Hepatitis A Vaccine Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Mono Hepatitis A Vaccine Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Mono Hepatitis A Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Mono Hepatitis A Vaccine Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Mono Hepatitis A Vaccine Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Mono Hepatitis A Vaccine Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Mono Hepatitis A Vaccine
Table 58. Key Market Challenges & Risks of Mono Hepatitis A Vaccine
Table 59. Key Industry Trends of Mono Hepatitis A Vaccine
Table 60. Mono Hepatitis A Vaccine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Mono Hepatitis A Vaccine Distributors List
Table 63. Mono Hepatitis A Vaccine Customer List
Table 64. Global Mono Hepatitis A Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Mono Hepatitis A Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Mono Hepatitis A Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Mono Hepatitis A Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Mono Hepatitis A Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Mono Hepatitis A Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Mono Hepatitis A Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Mono Hepatitis A Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Mono Hepatitis A Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Mono Hepatitis A Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Mono Hepatitis A Vaccine Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Mono Hepatitis A Vaccine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Mono Hepatitis A Vaccine Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Mono Hepatitis A Vaccine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. GSK Basic Information, Mono Hepatitis A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. GSK Mono Hepatitis A Vaccine Product Portfolios and Specifications
Table 80. GSK Mono Hepatitis A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. GSK Main Business
Table 82. GSK Latest Developments
Table 83. Merck Basic Information, Mono Hepatitis A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. Merck Mono Hepatitis A Vaccine Product Portfolios and Specifications
Table 85. Merck Mono Hepatitis A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Merck Main Business
Table 87. Merck Latest Developments
Table 88. Sanofi Basic Information, Mono Hepatitis A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Sanofi Mono Hepatitis A Vaccine Product Portfolios and Specifications
Table 90. Sanofi Mono Hepatitis A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Sanofi Main Business
Table 92. Sanofi Latest Developments
Table 93. Sinovac Basic Information, Mono Hepatitis A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. Sinovac Mono Hepatitis A Vaccine Product Portfolios and Specifications
Table 95. Sinovac Mono Hepatitis A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Sinovac Main Business
Table 97. Sinovac Latest Developments
Table 98. Zhejiang Pukang Basic Information, Mono Hepatitis A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. Zhejiang Pukang Mono Hepatitis A Vaccine Product Portfolios and Specifications
Table 100. Zhejiang Pukang Mono Hepatitis A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Zhejiang Pukang Main Business
Table 102. Zhejiang Pukang Latest Developments
Table 103. Changchun Institute of Biological Basic Information, Mono Hepatitis A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. Changchun Institute of Biological Mono Hepatitis A Vaccine Product Portfolios and Specifications
Table 105. Changchun Institute of Biological Mono Hepatitis A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Changchun Institute of Biological Main Business
Table 107. Changchun Institute of Biological Latest Developments
Table 108. Kaketsuken Basic Information, Mono Hepatitis A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. Kaketsuken Mono Hepatitis A Vaccine Product Portfolios and Specifications
Table 110. Kaketsuken Mono Hepatitis A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Kaketsuken Main Business
Table 112. Kaketsuken Latest Developments
Table 113. IMBCA Basic Information, Mono Hepatitis A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. IMBCA Mono Hepatitis A Vaccine Product Portfolios and Specifications
Table 115. IMBCA Mono Hepatitis A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. IMBCA Main Business
Table 117. IMBCA Latest Developments
Table 118. ChangSheng Basic Information, Mono Hepatitis A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 119. ChangSheng Mono Hepatitis A Vaccine Product Portfolios and Specifications
Table 120. ChangSheng Mono Hepatitis A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. ChangSheng Main Business
Table 122. ChangSheng Latest Developments
Table 123. Convac Basic Information, Mono Hepatitis A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 124. Convac Mono Hepatitis A Vaccine Product Portfolios and Specifications
Table 125. Convac Mono Hepatitis A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Convac Main Business
Table 127. Convac Latest Developments
Table 1. Mono Hepatitis A Vaccine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Mono Hepatitis A Vaccine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Inactivated Vaccine
Table 4. Major Players of Live Attenuated Vaccine
Table 5. Global Mono Hepatitis A Vaccine Sales by Type (2018-2023) & (K Units)
Table 6. Global Mono Hepatitis A Vaccine Sales Market Share by Type (2018-2023)
Table 7. Global Mono Hepatitis A Vaccine Revenue by Type (2018-2023) & ($ million)
Table 8. Global Mono Hepatitis A Vaccine Revenue Market Share by Type (2018-2023)
Table 9. Global Mono Hepatitis A Vaccine Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Mono Hepatitis A Vaccine Sales by Application (2018-2023) & (K Units)
Table 11. Global Mono Hepatitis A Vaccine Sales Market Share by Application (2018-2023)
Table 12. Global Mono Hepatitis A Vaccine Revenue by Application (2018-2023)
Table 13. Global Mono Hepatitis A Vaccine Revenue Market Share by Application (2018-2023)
Table 14. Global Mono Hepatitis A Vaccine Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Mono Hepatitis A Vaccine Sales by Company (2018-2023) & (K Units)
Table 16. Global Mono Hepatitis A Vaccine Sales Market Share by Company (2018-2023)
Table 17. Global Mono Hepatitis A Vaccine Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Mono Hepatitis A Vaccine Revenue Market Share by Company (2018-2023)
Table 19. Global Mono Hepatitis A Vaccine Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Mono Hepatitis A Vaccine Producing Area Distribution and Sales Area
Table 21. Players Mono Hepatitis A Vaccine Products Offered
Table 22. Mono Hepatitis A Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Mono Hepatitis A Vaccine Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Mono Hepatitis A Vaccine Sales Market Share Geographic Region (2018-2023)
Table 27. Global Mono Hepatitis A Vaccine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Mono Hepatitis A Vaccine Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Mono Hepatitis A Vaccine Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Mono Hepatitis A Vaccine Sales Market Share by Country/Region (2018-2023)
Table 31. Global Mono Hepatitis A Vaccine Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Mono Hepatitis A Vaccine Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Mono Hepatitis A Vaccine Sales by Country (2018-2023) & (K Units)
Table 34. Americas Mono Hepatitis A Vaccine Sales Market Share by Country (2018-2023)
Table 35. Americas Mono Hepatitis A Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Mono Hepatitis A Vaccine Revenue Market Share by Country (2018-2023)
Table 37. Americas Mono Hepatitis A Vaccine Sales by Type (2018-2023) & (K Units)
Table 38. Americas Mono Hepatitis A Vaccine Sales by Application (2018-2023) & (K Units)
Table 39. APAC Mono Hepatitis A Vaccine Sales by Region (2018-2023) & (K Units)
Table 40. APAC Mono Hepatitis A Vaccine Sales Market Share by Region (2018-2023)
Table 41. APAC Mono Hepatitis A Vaccine Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Mono Hepatitis A Vaccine Revenue Market Share by Region (2018-2023)
Table 43. APAC Mono Hepatitis A Vaccine Sales by Type (2018-2023) & (K Units)
Table 44. APAC Mono Hepatitis A Vaccine Sales by Application (2018-2023) & (K Units)
Table 45. Europe Mono Hepatitis A Vaccine Sales by Country (2018-2023) & (K Units)
Table 46. Europe Mono Hepatitis A Vaccine Sales Market Share by Country (2018-2023)
Table 47. Europe Mono Hepatitis A Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Mono Hepatitis A Vaccine Revenue Market Share by Country (2018-2023)
Table 49. Europe Mono Hepatitis A Vaccine Sales by Type (2018-2023) & (K Units)
Table 50. Europe Mono Hepatitis A Vaccine Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Mono Hepatitis A Vaccine Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Mono Hepatitis A Vaccine Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Mono Hepatitis A Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Mono Hepatitis A Vaccine Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Mono Hepatitis A Vaccine Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Mono Hepatitis A Vaccine Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Mono Hepatitis A Vaccine
Table 58. Key Market Challenges & Risks of Mono Hepatitis A Vaccine
Table 59. Key Industry Trends of Mono Hepatitis A Vaccine
Table 60. Mono Hepatitis A Vaccine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Mono Hepatitis A Vaccine Distributors List
Table 63. Mono Hepatitis A Vaccine Customer List
Table 64. Global Mono Hepatitis A Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Mono Hepatitis A Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Mono Hepatitis A Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Mono Hepatitis A Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Mono Hepatitis A Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Mono Hepatitis A Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Mono Hepatitis A Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Mono Hepatitis A Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Mono Hepatitis A Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Mono Hepatitis A Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Mono Hepatitis A Vaccine Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Mono Hepatitis A Vaccine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Mono Hepatitis A Vaccine Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Mono Hepatitis A Vaccine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. GSK Basic Information, Mono Hepatitis A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. GSK Mono Hepatitis A Vaccine Product Portfolios and Specifications
Table 80. GSK Mono Hepatitis A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. GSK Main Business
Table 82. GSK Latest Developments
Table 83. Merck Basic Information, Mono Hepatitis A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. Merck Mono Hepatitis A Vaccine Product Portfolios and Specifications
Table 85. Merck Mono Hepatitis A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Merck Main Business
Table 87. Merck Latest Developments
Table 88. Sanofi Basic Information, Mono Hepatitis A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Sanofi Mono Hepatitis A Vaccine Product Portfolios and Specifications
Table 90. Sanofi Mono Hepatitis A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Sanofi Main Business
Table 92. Sanofi Latest Developments
Table 93. Sinovac Basic Information, Mono Hepatitis A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. Sinovac Mono Hepatitis A Vaccine Product Portfolios and Specifications
Table 95. Sinovac Mono Hepatitis A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Sinovac Main Business
Table 97. Sinovac Latest Developments
Table 98. Zhejiang Pukang Basic Information, Mono Hepatitis A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. Zhejiang Pukang Mono Hepatitis A Vaccine Product Portfolios and Specifications
Table 100. Zhejiang Pukang Mono Hepatitis A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Zhejiang Pukang Main Business
Table 102. Zhejiang Pukang Latest Developments
Table 103. Changchun Institute of Biological Basic Information, Mono Hepatitis A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. Changchun Institute of Biological Mono Hepatitis A Vaccine Product Portfolios and Specifications
Table 105. Changchun Institute of Biological Mono Hepatitis A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Changchun Institute of Biological Main Business
Table 107. Changchun Institute of Biological Latest Developments
Table 108. Kaketsuken Basic Information, Mono Hepatitis A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. Kaketsuken Mono Hepatitis A Vaccine Product Portfolios and Specifications
Table 110. Kaketsuken Mono Hepatitis A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Kaketsuken Main Business
Table 112. Kaketsuken Latest Developments
Table 113. IMBCA Basic Information, Mono Hepatitis A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. IMBCA Mono Hepatitis A Vaccine Product Portfolios and Specifications
Table 115. IMBCA Mono Hepatitis A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. IMBCA Main Business
Table 117. IMBCA Latest Developments
Table 118. ChangSheng Basic Information, Mono Hepatitis A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 119. ChangSheng Mono Hepatitis A Vaccine Product Portfolios and Specifications
Table 120. ChangSheng Mono Hepatitis A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. ChangSheng Main Business
Table 122. ChangSheng Latest Developments
Table 123. Convac Basic Information, Mono Hepatitis A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 124. Convac Mono Hepatitis A Vaccine Product Portfolios and Specifications
Table 125. Convac Mono Hepatitis A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Convac Main Business
Table 127. Convac Latest Developments
LIST OF FIGURES
Figure 1. Picture of Mono Hepatitis A Vaccine
Figure 2. Mono Hepatitis A Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Mono Hepatitis A Vaccine Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Mono Hepatitis A Vaccine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Mono Hepatitis A Vaccine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Inactivated Vaccine
Figure 10. Product Picture of Live Attenuated Vaccine
Figure 11. Global Mono Hepatitis A Vaccine Sales Market Share by Type in 2022
Figure 12. Global Mono Hepatitis A Vaccine Revenue Market Share by Type (2018-2023)
Figure 13. Mono Hepatitis A Vaccine Consumed in Government Institution
Figure 14. Global Mono Hepatitis A Vaccine Market: Government Institution (2018-2023) & (K Units)
Figure 15. Mono Hepatitis A Vaccine Consumed in Private Sector
Figure 16. Global Mono Hepatitis A Vaccine Market: Private Sector (2018-2023) & (K Units)
Figure 17. Mono Hepatitis A Vaccine Consumed in Other
Figure 18. Global Mono Hepatitis A Vaccine Market: Other (2018-2023) & (K Units)
Figure 19. Global Mono Hepatitis A Vaccine Sales Market Share by Application (2022)
Figure 20. Global Mono Hepatitis A Vaccine Revenue Market Share by Application in 2022
Figure 21. Mono Hepatitis A Vaccine Sales Market by Company in 2022 (K Units)
Figure 22. Global Mono Hepatitis A Vaccine Sales Market Share by Company in 2022
Figure 23. Mono Hepatitis A Vaccine Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Mono Hepatitis A Vaccine Revenue Market Share by Company in 2022
Figure 25. Global Mono Hepatitis A Vaccine Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Mono Hepatitis A Vaccine Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Mono Hepatitis A Vaccine Sales 2018-2023 (K Units)
Figure 28. Americas Mono Hepatitis A Vaccine Revenue 2018-2023 ($ Millions)
Figure 29. APAC Mono Hepatitis A Vaccine Sales 2018-2023 (K Units)
Figure 30. APAC Mono Hepatitis A Vaccine Revenue 2018-2023 ($ Millions)
Figure 31. Europe Mono Hepatitis A Vaccine Sales 2018-2023 (K Units)
Figure 32. Europe Mono Hepatitis A Vaccine Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Mono Hepatitis A Vaccine Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Mono Hepatitis A Vaccine Revenue 2018-2023 ($ Millions)
Figure 35. Americas Mono Hepatitis A Vaccine Sales Market Share by Country in 2022
Figure 36. Americas Mono Hepatitis A Vaccine Revenue Market Share by Country in 2022
Figure 37. Americas Mono Hepatitis A Vaccine Sales Market Share by Type (2018-2023)
Figure 38. Americas Mono Hepatitis A Vaccine Sales Market Share by Application (2018-2023)
Figure 39. United States Mono Hepatitis A Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Mono Hepatitis A Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Mono Hepatitis A Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Mono Hepatitis A Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Mono Hepatitis A Vaccine Sales Market Share by Region in 2022
Figure 44. APAC Mono Hepatitis A Vaccine Revenue Market Share by Regions in 2022
Figure 45. APAC Mono Hepatitis A Vaccine Sales Market Share by Type (2018-2023)
Figure 46. APAC Mono Hepatitis A Vaccine Sales Market Share by Application (2018-2023)
Figure 47. China Mono Hepatitis A Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Mono Hepatitis A Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Mono Hepatitis A Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Mono Hepatitis A Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Mono Hepatitis A Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Mono Hepatitis A Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Mono Hepatitis A Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Mono Hepatitis A Vaccine Sales Market Share by Country in 2022
Figure 55. Europe Mono Hepatitis A Vaccine Revenue Market Share by Country in 2022
Figure 56. Europe Mono Hepatitis A Vaccine Sales Market Share by Type (2018-2023)
Figure 57. Europe Mono Hepatitis A Vaccine Sales Market Share by Application (2018-2023)
Figure 58. Germany Mono Hepatitis A Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Mono Hepatitis A Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Mono Hepatitis A Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Mono Hepatitis A Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Mono Hepatitis A Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Mono Hepatitis A Vaccine Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Mono Hepatitis A Vaccine Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Mono Hepatitis A Vaccine Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Mono Hepatitis A Vaccine Sales Market Share by Application (2018-2023)
Figure 67. Egypt Mono Hepatitis A Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Mono Hepatitis A Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Mono Hepatitis A Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Mono Hepatitis A Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Mono Hepatitis A Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Mono Hepatitis A Vaccine in 2022
Figure 73. Manufacturing Process Analysis of Mono Hepatitis A Vaccine
Figure 74. Industry Chain Structure of Mono Hepatitis A Vaccine
Figure 75. Channels of Distribution
Figure 76. Global Mono Hepatitis A Vaccine Sales Market Forecast by Region (2024-2029)
Figure 77. Global Mono Hepatitis A Vaccine Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Mono Hepatitis A Vaccine Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Mono Hepatitis A Vaccine Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Mono Hepatitis A Vaccine Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Mono Hepatitis A Vaccine Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Mono Hepatitis A Vaccine
Figure 2. Mono Hepatitis A Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Mono Hepatitis A Vaccine Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Mono Hepatitis A Vaccine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Mono Hepatitis A Vaccine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Inactivated Vaccine
Figure 10. Product Picture of Live Attenuated Vaccine
Figure 11. Global Mono Hepatitis A Vaccine Sales Market Share by Type in 2022
Figure 12. Global Mono Hepatitis A Vaccine Revenue Market Share by Type (2018-2023)
Figure 13. Mono Hepatitis A Vaccine Consumed in Government Institution
Figure 14. Global Mono Hepatitis A Vaccine Market: Government Institution (2018-2023) & (K Units)
Figure 15. Mono Hepatitis A Vaccine Consumed in Private Sector
Figure 16. Global Mono Hepatitis A Vaccine Market: Private Sector (2018-2023) & (K Units)
Figure 17. Mono Hepatitis A Vaccine Consumed in Other
Figure 18. Global Mono Hepatitis A Vaccine Market: Other (2018-2023) & (K Units)
Figure 19. Global Mono Hepatitis A Vaccine Sales Market Share by Application (2022)
Figure 20. Global Mono Hepatitis A Vaccine Revenue Market Share by Application in 2022
Figure 21. Mono Hepatitis A Vaccine Sales Market by Company in 2022 (K Units)
Figure 22. Global Mono Hepatitis A Vaccine Sales Market Share by Company in 2022
Figure 23. Mono Hepatitis A Vaccine Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Mono Hepatitis A Vaccine Revenue Market Share by Company in 2022
Figure 25. Global Mono Hepatitis A Vaccine Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Mono Hepatitis A Vaccine Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Mono Hepatitis A Vaccine Sales 2018-2023 (K Units)
Figure 28. Americas Mono Hepatitis A Vaccine Revenue 2018-2023 ($ Millions)
Figure 29. APAC Mono Hepatitis A Vaccine Sales 2018-2023 (K Units)
Figure 30. APAC Mono Hepatitis A Vaccine Revenue 2018-2023 ($ Millions)
Figure 31. Europe Mono Hepatitis A Vaccine Sales 2018-2023 (K Units)
Figure 32. Europe Mono Hepatitis A Vaccine Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Mono Hepatitis A Vaccine Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Mono Hepatitis A Vaccine Revenue 2018-2023 ($ Millions)
Figure 35. Americas Mono Hepatitis A Vaccine Sales Market Share by Country in 2022
Figure 36. Americas Mono Hepatitis A Vaccine Revenue Market Share by Country in 2022
Figure 37. Americas Mono Hepatitis A Vaccine Sales Market Share by Type (2018-2023)
Figure 38. Americas Mono Hepatitis A Vaccine Sales Market Share by Application (2018-2023)
Figure 39. United States Mono Hepatitis A Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Mono Hepatitis A Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Mono Hepatitis A Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Mono Hepatitis A Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Mono Hepatitis A Vaccine Sales Market Share by Region in 2022
Figure 44. APAC Mono Hepatitis A Vaccine Revenue Market Share by Regions in 2022
Figure 45. APAC Mono Hepatitis A Vaccine Sales Market Share by Type (2018-2023)
Figure 46. APAC Mono Hepatitis A Vaccine Sales Market Share by Application (2018-2023)
Figure 47. China Mono Hepatitis A Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Mono Hepatitis A Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Mono Hepatitis A Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Mono Hepatitis A Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Mono Hepatitis A Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Mono Hepatitis A Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Mono Hepatitis A Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Mono Hepatitis A Vaccine Sales Market Share by Country in 2022
Figure 55. Europe Mono Hepatitis A Vaccine Revenue Market Share by Country in 2022
Figure 56. Europe Mono Hepatitis A Vaccine Sales Market Share by Type (2018-2023)
Figure 57. Europe Mono Hepatitis A Vaccine Sales Market Share by Application (2018-2023)
Figure 58. Germany Mono Hepatitis A Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Mono Hepatitis A Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Mono Hepatitis A Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Mono Hepatitis A Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Mono Hepatitis A Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Mono Hepatitis A Vaccine Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Mono Hepatitis A Vaccine Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Mono Hepatitis A Vaccine Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Mono Hepatitis A Vaccine Sales Market Share by Application (2018-2023)
Figure 67. Egypt Mono Hepatitis A Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Mono Hepatitis A Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Mono Hepatitis A Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Mono Hepatitis A Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Mono Hepatitis A Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Mono Hepatitis A Vaccine in 2022
Figure 73. Manufacturing Process Analysis of Mono Hepatitis A Vaccine
Figure 74. Industry Chain Structure of Mono Hepatitis A Vaccine
Figure 75. Channels of Distribution
Figure 76. Global Mono Hepatitis A Vaccine Sales Market Forecast by Region (2024-2029)
Figure 77. Global Mono Hepatitis A Vaccine Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Mono Hepatitis A Vaccine Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Mono Hepatitis A Vaccine Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Mono Hepatitis A Vaccine Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Mono Hepatitis A Vaccine Revenue Market Share Forecast by Application (2024-2029)
